Status: current, Defined. Date: 31-Jul 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5089563011 | Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
5089564017 | Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besylate) 2.5 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
5089565016 | Product containing precisely hydrochlorothiazide 12.5 milligram and levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Is a | Hydrochlorothiazide and levamlodipine only product in oral dose form | true | Inferred relationship | Some | ||
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has precise active ingredient | Levamlodipine besilate | true | Inferred relationship | Some | 1 | |
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has BoSS | Levamlodipine | true | Inferred relationship | Some | 1 | |
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has precise active ingredient | Hydrochlorothiazide | true | Inferred relationship | Some | 2 | |
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has BoSS | Hydrochlorothiazide | true | Inferred relationship | Some | 2 | |
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets